Fetal and Maternal Safety Considerations for In Utero Therapy Clinical Trials: iFeTiS Consensus Statement

Rachel Sagar, Graça Almeida-Porada, Karin Blakemore, Jerry K.Y. Chan, Mahesh Choolani, Cecilia Götherström, Agnes Jaulent, Tippi C. MacKenzie, Citra Mattar, Christopher D. Porada, William H. Peranteau, Holm Schneider, Steven W. Shaw, Simon N. Waddington, Magnus Westgren, Anna L. David

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish (US)
Pages (from-to)2316-2319
Number of pages4
JournalMolecular Therapy
Volume28
Issue number11
DOIs
StatePublished - Nov 4 2020
Externally publishedYes

Keywords

  • adverse event
  • clinical trial
  • fetal
  • fetal therapy
  • In utero stem cell transplantation
  • maternal
  • safety

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Pharmacology
  • Drug Discovery

Cite this